elderly

2:25
Analyzing AML: novel therapies in review
Farhad Ravandi
1:30
Geriatric assessment in multiple myeloma: is it required?
Alessandra Larocca
1:00
MRD as a response assessment in elderly multiple myeloma
Alessandra Larocca
1:57
Breakthroughs in the treatment of elderly patients with AML
Farhad Ravandi
1:05
When is the use of MRD appropriate?
Rafael Fonseca
2:24
Elderly cancer patients who report symptoms have greater survival
Raúl Córdoba
4:17
Methods to improve elderly lymphoma patient treatment
Raúl Córdoba
2:36
Hodgkin lymphoma: difficulties faced in geriatrics
Wendy Osborne
3:09
CAVEAT: venetoclax and high dose chemo for elderly AML
Andrew Wei
1:20
Patient fitness is a better criterion for treatment than age in MM
Mohamad Mohty
1:13
Optimizing elderly MM patient treatment
Mohamad Mohty
1:40
MRD evaluation in clinical practice for MM
Elena Zamagni
2:51
Redundancy of age restrictions for MM treatment
Mohamad Mohty
1:26
Treatment benefits for elderly AML patients with azacitidine
Esther Oliva
1:07
Identifying predictive factors of outcome in elderly lymphoma
Raúl Córdoba
1:03
Geriatric oncology: immunotherapy for elderly patients with lymphoma
Raúl Córdoba
VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

VJHO needs the contact information you provide to inform you about our latest hemonc news and videos, educational courses and industry supported content (some of which may be promotional in nature). You may unsubscribe from these communications at anytime. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.

The content of VJHemOnc is intended for healthcare professionals